INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 319 filers reported holding INTELLIA THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.64 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $63,240 | -53.3% | 2,000 | -39.8% | 0.00% | -50.0% |
| Q2 2023 | $135,471 | +9.4% | 3,322 | 0.0% | 0.01% | 0.0% |
| Q1 2023 | $123,811 | +106633.6% | 3,322 | 0.0% | 0.01% | +20.0% |
| Q4 2022 | $116 | -99.9% | 3,322 | 0.0% | 0.01% | -44.4% |
| Q3 2022 | $186,000 | +8.1% | 3,322 | 0.0% | 0.01% | +12.5% |
| Q2 2022 | $172,000 | -28.6% | 3,322 | 0.0% | 0.01% | 0.0% |
| Q1 2022 | $241,000 | -38.5% | 3,322 | 0.0% | 0.01% | -38.5% |
| Q4 2021 | $392,000 | +83.2% | 3,322 | +151.3% | 0.01% | +62.5% |
| Q2 2021 | $214,000 | – | 1,322 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HIMENSION CAPITAL (SINGAPORE) PTE. LTD. | 744,160 | $54,078,000 | 5.79% |
| Discovery Value Fund | 986,173 | $71,665,000 | 5.28% |
| Ally Bridge Group (NY) LLC | 60,000 | $4,360,000 | 3.23% |
| MPM BioImpact LLC | 159,409 | $11,584,000 | 3.11% |
| ARK Investment Management | 8,981,029 | $652,651,000 | 2.72% |
| Elmwood Wealth Management, Inc. | 67,599 | $4,912,000 | 2.52% |
| Nikko Asset Management Americas, Inc. | 2,872,269 | $192,442,000 | 1.41% |
| Frazier Life Sciences Management, L.P. | 203,684 | $14,802,000 | 1.26% |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 111,440 | $8,098,000 | 1.22% |
| Merlin Capital, Inc | 11,575 | $841,000 | 1.11% |